Study to improve HIV medicine adherence reminders
Part of Immune system & allergy, Infections clinical trials.
This study looks at a way to help people take their HIV medicines as prescribed. It focuses on people who are HIV-positive and not currently taking their treatment consistently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed HIV-positive diagnosis
- You must be currently prescribed HIV (antiretroviral) medicines
- You must be having trouble taking your HIV medicines regularly
- You must have reliable phone access
- You must have reliable internet access
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help people living with HIV who have difficulty taking their medications consistently. The goal is to see if extra support can improve health outcomes.
This is an observational study that follows people with HIV who are taking HIV medicines (antiretroviral therapy). It may help researchers understand how treatment is going and what factors relate to doing well on therapy.
This study tests whether special “U=U” style messages can improve how men move from HIV testing to starting treatment and continuing care. You may be asked to receive guidance and information meant to help you stay engaged in HIV treatment.
This study tests a special pill that has a sensor inside, which sends information to your doctor or care team to help you remember to take your HIV medication. It is for people who sometimes miss doses and want extra support.
This study tests whether daily text message reminders and a small tracking device (WisePill) can help people who recently started HIV medication stay on track. It's designed for people who began treatment in the past 2 months and are willing to receive texts and use the device.
This study tests a counseling program (bio-behavioral intervention) designed to help people with HIV keep their virus levels under control over time. It may be especially relevant if your current HIV treatment has been hard to stick with or you haven’t had recent viral load checks.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.